ALAUNOS THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
ALAUNOS THERAPEUTICS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include HUNTR, ZIOPHARM, and ALAUNOS THERAPEUTICS. The owner is based in Houston, TX.
2617 Bissonnet, Suite 225
Houston, TX 77005
Showing of trademarks Trademarks
Trademark Classifications
ALAUNOS THERAPEUTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ALAUNOS THERAPEUTICS, INC. have?
ALAUNOS THERAPEUTICS, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned.
What trademark classes does ALAUNOS THERAPEUTICS, INC. file in?
ALAUNOS THERAPEUTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ALAUNOS THERAPEUTICS, INC.'s most well-known trademarks?
ALAUNOS THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as HUNTR, ZIOPHARM, and ALAUNOS THERAPEUTICS. These are among 7 currently registered trademarks in the portfolio.
What is ALAUNOS THERAPEUTICS, INC.'s trademark registration success rate?
ALAUNOS THERAPEUTICS, INC. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.